Polymerase Chain Reaction Technologies Market By Technology (Real-Time PCR, Traditional PCR, Digital PCR), By Product (Reagents & Consumables, Instruments, Software, Services), By End Users (Diagnostic Centers & Hospitals, Biotech & Pharma Companies, Acad
Description
Polymerase Chain Reaction Technologies Market By Technology (Real-Time PCR, Traditional PCR, Digital PCR), By Product (Reagents & Consumables, Instruments, Software, Services), By End Users (Diagnostic Centers & Hospitals, Biotech & Pharma Companies, Academic & Research Institutions): Global Opportunity Analysis and Industry Forecast, 2020-2030
The global polymerase chain reaction technology market size was $16,669.3 million in 2020, and is expected to reach $28,755.1 million by 2030, with a CAGR of 4.1% from 2021 to 2030. Polymerase chain reaction (PCR) is a huge consistent methodology in the molecular biological science that upgrades single or barely any copies of a piece of DNA. Similarly, it is valuable in making thousands to millions of copies of a particular DNA gathering and investigating ailments such as AIDS, tuberculosis, Lyme disorder, and center ear infections. The development incorporates three huge advances; denaturation, hardening, and extension. It is applicable in clinical, research, clinical diagnostics, and legitimate sciences. It has been utilized since seemingly forever as a standard method for research on nucleic acids (RNA and DNA) in labs. PCR progresses available in the market are nonstop quantitative (qPCR), mechanized PCR (dPCR), computerized PCR, multiplex PCR, gathering PCR, and standard PCR. The need of strong illustrative diagnostic system in clinical consideration to perceive ailments empowers the premium for the advancement of the market.
Advancement in growth of infection and overwhelming contamination drive the polymerase chain reaction technologies market. For instance, cancer is one of the primary reasons of death across the globe. As per the National Cancer Institute, numerous people experience the ill effects of cancer. On account of the climb in the amount of patients encountering consistent contaminations, there is a development in the premium for PCR headways for the early investigation of sicknesses. From now on, various institutions have started with the therapy at the earliest, with the development in the inescapability of the infections. There is development in the interest in PCR advancements to perceive these afflictions toward the starting stages. Consequently, this positively impacts the development of the market. In addition, the progression in PCR propels by key part in industry help the advancement of the market by making advanced solutions open to the clinical services specialists for acknowledgment of various kinds of powerful disorders, threatening development, blood screening, and various applications, which drive the polymerase chain reaction technology market.
However, PCR tests can be used for the examination of various contaminations. Regardless, the cost related with the use of PCR progressions for the indicative tests are high. Consequently, patients do not select such tests. In like manner, various countries do not give reimbursement to these tests. The execution of these rates would achieve decline in reimbursement for key molecular tests, including inherited disease, molecular cytogenetics, and cancer testing. Consequently, nonappearance of reimbursements options further hinders the polymerase chain reaction technologies market growth for PCR developments.
On the contrary, the ascent in the occurrence of the infection and sicknesses such as cancer growth and contamination has expanded the interest of the characteristic techniques that could help in the early acknowledgment of these diseases. This has incited a development in sponsoring for the R&D activities that could help in the early finding of these diseases. In addition, critical associations put assets into the progress of the molecular diagnostics, for instance, PCR, expecting the development and demand in the field. The extension in sponsoring for R&D practices that incorporates the use of PCR for various purposes could extend the use of these advances and could offer new polymerase chain reaction technologies opportunity.
The Polymerase chain reaction technology market is segmented on the basis of technology, product, application, end user industry, and region. By technology, the market is divided into real-time PCR, traditional PCR, and digital PCR. By product, the market is fragmented into reagents & consumables, instruments, software, and services. By application, the market is classified into clinical, research, and forensics. By end user, the market is divided into diagnostic centers & hospitals, biotech & pharma companies, and academic & research institutions. Region wise, the market is analyzed across North America (the U.S., Canada, and Mexico), Europe (Germany, France, Italy, Spain, and rest of Europe), Asia-Pacific (China, Japan, South Korea, India, and rest of Asia-Pacific), and LAMEA (Latin America, the Middle East, and Africa).
The major players profiled in the polymerase chain reaction technology market include Abcam plc. (Expedeon AG), Agilent Technologies, Inc., bioMerieux SA, Bio-Rad Laboratories, Inc. , F. Hoffmann-La Roche Ltd , Fluidigm , LGC Limited , Qiagen, Takara Bio Inc. , Thermo Fisher Scientific Inc.Major companies in the market have adopted product launch, partnership, and agreement as their key developmental strategies to offer better products and services to customers in the Polymerase chain reaction technology market.
Key Benefits For Stakeholders
This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the polymerase chain reaction technologies market opportunity.
The market research is offered along with information related to key drivers, restraints, and opportunities.
Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
In-depth analysis of the polymerase chain reaction technologies market segmentation assists to determine the prevailing market opportunities.
Major countries in each region are mapped according to their revenue contribution to the global market.
Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
The report includes the analysis of the regional as well as global polymerase chain reaction technologies market trends, key players, market segments, application areas, and market growth strategies.
Key Market Segments
By End Users
Diagnostic Centers Hospitals
Biotech Pharma Companies
Academic Research Institutions
By Technology
Real-Time PCR
Traditional PCR
Digital PCR
By Product
Reagents Consumables
Instruments
Software
Services
By Region
Europe
Germany
United Kingdom
France
Italy
Rest of Europe
Asia-Pacific
China
Japan
South Korea
India
Rest of Asia-Pacific
North America
U.S.
Canada
Mexico
LAMEA
Latin America
Middle East
Africa
Key Market Players
AGILENT TECHNOLOGIES
INC
BIOMERIEUX S.A
BIO-RAD LABORATORIES
INC
F. HOFFMANN-LA ROCHE AG (ROCHE)
FLUIDIGM CORPORATION
LGC LIMITED
QIAGEN N.V
SYGNIS AG
TAKARA BIO INC
THERMO FISHER SCIENTIFIC INC
The global polymerase chain reaction technology market size was $16,669.3 million in 2020, and is expected to reach $28,755.1 million by 2030, with a CAGR of 4.1% from 2021 to 2030. Polymerase chain reaction (PCR) is a huge consistent methodology in the molecular biological science that upgrades single or barely any copies of a piece of DNA. Similarly, it is valuable in making thousands to millions of copies of a particular DNA gathering and investigating ailments such as AIDS, tuberculosis, Lyme disorder, and center ear infections. The development incorporates three huge advances; denaturation, hardening, and extension. It is applicable in clinical, research, clinical diagnostics, and legitimate sciences. It has been utilized since seemingly forever as a standard method for research on nucleic acids (RNA and DNA) in labs. PCR progresses available in the market are nonstop quantitative (qPCR), mechanized PCR (dPCR), computerized PCR, multiplex PCR, gathering PCR, and standard PCR. The need of strong illustrative diagnostic system in clinical consideration to perceive ailments empowers the premium for the advancement of the market.
Advancement in growth of infection and overwhelming contamination drive the polymerase chain reaction technologies market. For instance, cancer is one of the primary reasons of death across the globe. As per the National Cancer Institute, numerous people experience the ill effects of cancer. On account of the climb in the amount of patients encountering consistent contaminations, there is a development in the premium for PCR headways for the early investigation of sicknesses. From now on, various institutions have started with the therapy at the earliest, with the development in the inescapability of the infections. There is development in the interest in PCR advancements to perceive these afflictions toward the starting stages. Consequently, this positively impacts the development of the market. In addition, the progression in PCR propels by key part in industry help the advancement of the market by making advanced solutions open to the clinical services specialists for acknowledgment of various kinds of powerful disorders, threatening development, blood screening, and various applications, which drive the polymerase chain reaction technology market.
However, PCR tests can be used for the examination of various contaminations. Regardless, the cost related with the use of PCR progressions for the indicative tests are high. Consequently, patients do not select such tests. In like manner, various countries do not give reimbursement to these tests. The execution of these rates would achieve decline in reimbursement for key molecular tests, including inherited disease, molecular cytogenetics, and cancer testing. Consequently, nonappearance of reimbursements options further hinders the polymerase chain reaction technologies market growth for PCR developments.
On the contrary, the ascent in the occurrence of the infection and sicknesses such as cancer growth and contamination has expanded the interest of the characteristic techniques that could help in the early acknowledgment of these diseases. This has incited a development in sponsoring for the R&D activities that could help in the early finding of these diseases. In addition, critical associations put assets into the progress of the molecular diagnostics, for instance, PCR, expecting the development and demand in the field. The extension in sponsoring for R&D practices that incorporates the use of PCR for various purposes could extend the use of these advances and could offer new polymerase chain reaction technologies opportunity.
The Polymerase chain reaction technology market is segmented on the basis of technology, product, application, end user industry, and region. By technology, the market is divided into real-time PCR, traditional PCR, and digital PCR. By product, the market is fragmented into reagents & consumables, instruments, software, and services. By application, the market is classified into clinical, research, and forensics. By end user, the market is divided into diagnostic centers & hospitals, biotech & pharma companies, and academic & research institutions. Region wise, the market is analyzed across North America (the U.S., Canada, and Mexico), Europe (Germany, France, Italy, Spain, and rest of Europe), Asia-Pacific (China, Japan, South Korea, India, and rest of Asia-Pacific), and LAMEA (Latin America, the Middle East, and Africa).
The major players profiled in the polymerase chain reaction technology market include Abcam plc. (Expedeon AG), Agilent Technologies, Inc., bioMerieux SA, Bio-Rad Laboratories, Inc. , F. Hoffmann-La Roche Ltd , Fluidigm , LGC Limited , Qiagen, Takara Bio Inc. , Thermo Fisher Scientific Inc.Major companies in the market have adopted product launch, partnership, and agreement as their key developmental strategies to offer better products and services to customers in the Polymerase chain reaction technology market.
Key Benefits For Stakeholders
This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the polymerase chain reaction technologies market opportunity.
The market research is offered along with information related to key drivers, restraints, and opportunities.
Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
In-depth analysis of the polymerase chain reaction technologies market segmentation assists to determine the prevailing market opportunities.
Major countries in each region are mapped according to their revenue contribution to the global market.
Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
The report includes the analysis of the regional as well as global polymerase chain reaction technologies market trends, key players, market segments, application areas, and market growth strategies.
Key Market Segments
By End Users
Diagnostic Centers Hospitals
Biotech Pharma Companies
Academic Research Institutions
By Technology
Real-Time PCR
Traditional PCR
Digital PCR
By Product
Reagents Consumables
Instruments
Software
Services
By Region
Europe
Germany
United Kingdom
France
Italy
Rest of Europe
Asia-Pacific
China
Japan
South Korea
India
Rest of Asia-Pacific
North America
U.S.
Canada
Mexico
LAMEA
Latin America
Middle East
Africa
Key Market Players
AGILENT TECHNOLOGIES
INC
BIOMERIEUX S.A
BIO-RAD LABORATORIES
INC
F. HOFFMANN-LA ROCHE AG (ROCHE)
FLUIDIGM CORPORATION
LGC LIMITED
QIAGEN N.V
SYGNIS AG
TAKARA BIO INC
THERMO FISHER SCIENTIFIC INC
Table of Contents
230 Pages
- CHAPTER 1:INTRODUCTION
- 1.1.Report description
- 1.2.Key market segments
- 1.3.Key benefits to the stakeholders
- 1.4.Research Methodology
- 1.4.1.Secondary research
- 1.4.2.Primary research
- 1.4.3.Analyst tools and models
- CHAPTER 2:EXECUTIVE SUMMARY
- 2.1.Key findings of the study
- 2.2.CXO Perspective
- CHAPTER 3:MARKET OVERVIEW
- 3.1.Market definition and scope
- 3.2.Key findings
- 3.2.1.Top investment pockets
- 3.3.Porter’s five forces analysis
- 3.4.Top player positioning
- 3.5.Market dynamics
- 3.5.1.Drivers
- 3.5.2.Restraints
- 3.5.3.Opportunities
- 3.6.COVID-19 Impact Analysis on the market
- CHAPTER 4: POLYMERASE CHAIN REACTION TECHNOLOGIES MARKET, BY TECHNOLOGY
- 4.1 Overview
- 4.1.1 Market size and forecast
- 4.2 Real-Time PCR
- 4.2.1 Key market trends, growth factors and opportunities
- 4.2.2 Market size and forecast, by region
- 4.2.3 Market analysis by country
- 4.3 Traditional PCR
- 4.3.1 Key market trends, growth factors and opportunities
- 4.3.2 Market size and forecast, by region
- 4.3.3 Market analysis by country
- 4.4 Digital PCR
- 4.4.1 Key market trends, growth factors and opportunities
- 4.4.2 Market size and forecast, by region
- 4.4.3 Market analysis by country
- CHAPTER 5: POLYMERASE CHAIN REACTION TECHNOLOGIES MARKET, BY PRODUCT
- 5.1 Overview
- 5.1.1 Market size and forecast
- 5.2 Reagents & Consumables
- 5.2.1 Key market trends, growth factors and opportunities
- 5.2.2 Market size and forecast, by region
- 5.2.3 Market analysis by country
- 5.3 Instruments
- 5.3.1 Key market trends, growth factors and opportunities
- 5.3.2 Market size and forecast, by region
- 5.3.3 Market analysis by country
- 5.4 Software
- 5.4.1 Key market trends, growth factors and opportunities
- 5.4.2 Market size and forecast, by region
- 5.4.3 Market analysis by country
- 5.5 Services
- 5.5.1 Key market trends, growth factors and opportunities
- 5.5.2 Market size and forecast, by region
- 5.5.3 Market analysis by country
- CHAPTER 6: POLYMERASE CHAIN REACTION TECHNOLOGIES MARKET, BY END USERS
- 6.1 Overview
- 6.1.1 Market size and forecast
- 6.2 Diagnostic Centers & Hospitals
- 6.2.1 Key market trends, growth factors and opportunities
- 6.2.2 Market size and forecast, by region
- 6.2.3 Market analysis by country
- 6.3 Biotech & Pharma Companies
- 6.3.1 Key market trends, growth factors and opportunities
- 6.3.2 Market size and forecast, by region
- 6.3.3 Market analysis by country
- 6.4 Academic & Research Institutions
- 6.4.1 Key market trends, growth factors and opportunities
- 6.4.2 Market size and forecast, by region
- 6.4.3 Market analysis by country
- CHAPTER 7: POLYMERASE CHAIN REACTION TECHNOLOGIES MARKET, BY REGION
- 7.1 Overview
- 7.1.1 Market size and forecast
- 7.2 Europe
- 7.2.1 Key trends and opportunities
- 7.2.2 Europe Market size and forecast, by Technology
- 7.2.3 Europe Market size and forecast, by Product
- 7.2.4 Europe Market size and forecast, by End Users
- 7.2.5 Europe Market size and forecast, by country
- 7.2.5.1 Germany
- 7.2.5.1.1 Market size and forecast, by Technology
- 7.2.5.1.2 Market size and forecast, by Product
- 7.2.5.1.3 Market size and forecast, by End Users
- 7.2.5.2 United Kingdom
- 7.2.5.2.1 Market size and forecast, by Technology
- 7.2.5.2.2 Market size and forecast, by Product
- 7.2.5.2.3 Market size and forecast, by End Users
- 7.2.5.3 France
- 7.2.5.3.1 Market size and forecast, by Technology
- 7.2.5.3.2 Market size and forecast, by Product
- 7.2.5.3.3 Market size and forecast, by End Users
- 7.2.5.4 Italy
- 7.2.5.4.1 Market size and forecast, by Technology
- 7.2.5.4.2 Market size and forecast, by Product
- 7.2.5.4.3 Market size and forecast, by End Users
- 7.2.5.5 Rest of Europe
- 7.2.5.5.1 Market size and forecast, by Technology
- 7.2.5.5.2 Market size and forecast, by Product
- 7.2.5.5.3 Market size and forecast, by End Users
- 7.3 Asia-Pacific
- 7.3.1 Key trends and opportunities
- 7.3.2 Asia-Pacific Market size and forecast, by Technology
- 7.3.3 Asia-Pacific Market size and forecast, by Product
- 7.3.4 Asia-Pacific Market size and forecast, by End Users
- 7.3.5 Asia-Pacific Market size and forecast, by country
- 7.3.5.1 China
- 7.3.5.1.1 Market size and forecast, by Technology
- 7.3.5.1.2 Market size and forecast, by Product
- 7.3.5.1.3 Market size and forecast, by End Users
- 7.3.5.2 Japan
- 7.3.5.2.1 Market size and forecast, by Technology
- 7.3.5.2.2 Market size and forecast, by Product
- 7.3.5.2.3 Market size and forecast, by End Users
- 7.3.5.3 South Korea
- 7.3.5.3.1 Market size and forecast, by Technology
- 7.3.5.3.2 Market size and forecast, by Product
- 7.3.5.3.3 Market size and forecast, by End Users
- 7.3.5.4 India
- 7.3.5.4.1 Market size and forecast, by Technology
- 7.3.5.4.2 Market size and forecast, by Product
- 7.3.5.4.3 Market size and forecast, by End Users
- 7.3.5.5 Rest of Asia-Pacific
- 7.3.5.5.1 Market size and forecast, by Technology
- 7.3.5.5.2 Market size and forecast, by Product
- 7.3.5.5.3 Market size and forecast, by End Users
- 7.4 North America
- 7.4.1 Key trends and opportunities
- 7.4.2 North America Market size and forecast, by Technology
- 7.4.3 North America Market size and forecast, by Product
- 7.4.4 North America Market size and forecast, by End Users
- 7.4.5 North America Market size and forecast, by country
- 7.4.5.1 U.S.
- 7.4.5.1.1 Market size and forecast, by Technology
- 7.4.5.1.2 Market size and forecast, by Product
- 7.4.5.1.3 Market size and forecast, by End Users
- 7.4.5.2 Canada
- 7.4.5.2.1 Market size and forecast, by Technology
- 7.4.5.2.2 Market size and forecast, by Product
- 7.4.5.2.3 Market size and forecast, by End Users
- 7.4.5.3 Mexico
- 7.4.5.3.1 Market size and forecast, by Technology
- 7.4.5.3.2 Market size and forecast, by Product
- 7.4.5.3.3 Market size and forecast, by End Users
- 7.5 LAMEA
- 7.5.1 Key trends and opportunities
- 7.5.2 LAMEA Market size and forecast, by Technology
- 7.5.3 LAMEA Market size and forecast, by Product
- 7.5.4 LAMEA Market size and forecast, by End Users
- 7.5.5 LAMEA Market size and forecast, by country
- 7.5.5.1 Latin America
- 7.5.5.1.1 Market size and forecast, by Technology
- 7.5.5.1.2 Market size and forecast, by Product
- 7.5.5.1.3 Market size and forecast, by End Users
- 7.5.5.2 Middle East
- 7.5.5.2.1 Market size and forecast, by Technology
- 7.5.5.2.2 Market size and forecast, by Product
- 7.5.5.2.3 Market size and forecast, by End Users
- 7.5.5.3 Africa
- 7.5.5.3.1 Market size and forecast, by Technology
- 7.5.5.3.2 Market size and forecast, by Product
- 7.5.5.3.3 Market size and forecast, by End Users
- CHAPTER 8: COMPANY LANDSCAPE
- 8.1. Introduction
- 8.2. Top winning strategies
- 8.3. Product Mapping of Top 10 Player
- 8.4. Competitive Dashboard
- 8.5. Competitive Heatmap
- 8.6. Key developments
- CHAPTER 9: COMPANY PROFILES
- 9.1 AGILENT TECHNOLOGIES
- 9.1.1 Company overview
- 9.1.2 Company snapshot
- 9.1.3 Operating business segments
- 9.1.4 Product portfolio
- 9.1.5 Business performance
- 9.1.6 Key strategic moves and developments
- 9.2 INC
- 9.2.1 Company overview
- 9.2.2 Company snapshot
- 9.2.3 Operating business segments
- 9.2.4 Product portfolio
- 9.2.5 Business performance
- 9.2.6 Key strategic moves and developments
- 9.3 BIOMERIEUX S.A
- 9.3.1 Company overview
- 9.3.2 Company snapshot
- 9.3.3 Operating business segments
- 9.3.4 Product portfolio
- 9.3.5 Business performance
- 9.3.6 Key strategic moves and developments
- 9.4 BIO-RAD LABORATORIES
- 9.4.1 Company overview
- 9.4.2 Company snapshot
- 9.4.3 Operating business segments
- 9.4.4 Product portfolio
- 9.4.5 Business performance
- 9.4.6 Key strategic moves and developments
- 9.5 INC
- 9.5.1 Company overview
- 9.5.2 Company snapshot
- 9.5.3 Operating business segments
- 9.5.4 Product portfolio
- 9.5.5 Business performance
- 9.5.6 Key strategic moves and developments
- 9.6 F. HOFFMANN-LA ROCHE AG (ROCHE)
- 9.6.1 Company overview
- 9.6.2 Company snapshot
- 9.6.3 Operating business segments
- 9.6.4 Product portfolio
- 9.6.5 Business performance
- 9.6.6 Key strategic moves and developments
- 9.7 FLUIDIGM CORPORATION
- 9.7.1 Company overview
- 9.7.2 Company snapshot
- 9.7.3 Operating business segments
- 9.7.4 Product portfolio
- 9.7.5 Business performance
- 9.7.6 Key strategic moves and developments
- 9.8 LGC LIMITED
- 9.8.1 Company overview
- 9.8.2 Company snapshot
- 9.8.3 Operating business segments
- 9.8.4 Product portfolio
- 9.8.5 Business performance
- 9.8.6 Key strategic moves and developments
- 9.9 QIAGEN N.V
- 9.9.1 Company overview
- 9.9.2 Company snapshot
- 9.9.3 Operating business segments
- 9.9.4 Product portfolio
- 9.9.5 Business performance
- 9.9.6 Key strategic moves and developments
- 9.10 SYGNIS AG
- 9.10.1 Company overview
- 9.10.2 Company snapshot
- 9.10.3 Operating business segments
- 9.10.4 Product portfolio
- 9.10.5 Business performance
- 9.10.6 Key strategic moves and developments
- 9.11 TAKARA BIO INC
- 9.11.1 Company overview
- 9.11.2 Company snapshot
- 9.11.3 Operating business segments
- 9.11.4 Product portfolio
- 9.11.5 Business performance
- 9.11.6 Key strategic moves and developments
- 9.12 THERMO FISHER SCIENTIFIC INC
- 9.12.1 Company overview
- 9.12.2 Company snapshot
- 9.12.3 Operating business segments
- 9.12.4 Product portfolio
- 9.12.5 Business performance
- 9.12.6 Key strategic moves and developments
- LIST OF TABLES
- TABLE 1. GLOBAL POLYMERASE CHAIN REACTION TECHNOLOGIES MARKET, BY TECHNOLOGY, 2020-2030,($MILLION)
- TABLE 2. POLYMERASE CHAIN REACTION TECHNOLOGIES MARKET REVENUE, FOR REAL-TIME PCR, BY REGION , 2020-2030,($MILLION)
- TABLE 3. POLYMERASE CHAIN REACTION TECHNOLOGIES MARKET REAL-TIME PCR BY COUNTRY, 2020-2030,($MILLION)
- TABLE 4. POLYMERASE CHAIN REACTION TECHNOLOGIES MARKET REVENUE, FOR TRADITIONAL PCR, BY REGION , 2020-2030,($MILLION)
- TABLE 5. POLYMERASE CHAIN REACTION TECHNOLOGIES MARKET TRADITIONAL PCR BY COUNTRY, 2020-2030,($MILLION)
- TABLE 6. POLYMERASE CHAIN REACTION TECHNOLOGIES MARKET REVENUE, FOR DIGITAL PCR, BY REGION , 2020-2030,($MILLION)
- TABLE 7. POLYMERASE CHAIN REACTION TECHNOLOGIES MARKET DIGITAL PCR BY COUNTRY, 2020-2030,($MILLION)
- TABLE 8. GLOBAL POLYMERASE CHAIN REACTION TECHNOLOGIES MARKET, BY PRODUCT, 2020-2030,($MILLION)
- TABLE 9. POLYMERASE CHAIN REACTION TECHNOLOGIES MARKET REVENUE, FOR REAGENTS & CONSUMABLES, BY REGION , 2020-2030,($MILLION)
- TABLE 10. POLYMERASE CHAIN REACTION TECHNOLOGIES MARKET REAGENTS & CONSUMABLES BY COUNTRY, 2020-2030,($MILLION)
- TABLE 11. POLYMERASE CHAIN REACTION TECHNOLOGIES MARKET REVENUE, FOR INSTRUMENTS, BY REGION , 2020-2030,($MILLION)
- TABLE 12. POLYMERASE CHAIN REACTION TECHNOLOGIES MARKET INSTRUMENTS BY COUNTRY, 2020-2030,($MILLION)
- TABLE 13. POLYMERASE CHAIN REACTION TECHNOLOGIES MARKET REVENUE, FOR SOFTWARE, BY REGION , 2020-2030,($MILLION)
- TABLE 14. POLYMERASE CHAIN REACTION TECHNOLOGIES MARKET SOFTWARE BY COUNTRY, 2020-2030,($MILLION)
- TABLE 15. POLYMERASE CHAIN REACTION TECHNOLOGIES MARKET REVENUE, FOR SERVICES, BY REGION , 2020-2030,($MILLION)
- TABLE 16. POLYMERASE CHAIN REACTION TECHNOLOGIES MARKET SERVICES BY COUNTRY, 2020-2030,($MILLION)
- TABLE 17. GLOBAL POLYMERASE CHAIN REACTION TECHNOLOGIES MARKET, BY END USERS, 2020-2030,($MILLION)
- TABLE 18. POLYMERASE CHAIN REACTION TECHNOLOGIES MARKET REVENUE, FOR DIAGNOSTIC CENTERS & HOSPITALS, BY REGION , 2020-2030,($MILLION)
- TABLE 19. POLYMERASE CHAIN REACTION TECHNOLOGIES MARKET DIAGNOSTIC CENTERS & HOSPITALS BY COUNTRY, 2020-2030,($MILLION)
- TABLE 20. POLYMERASE CHAIN REACTION TECHNOLOGIES MARKET REVENUE, FOR BIOTECH & PHARMA COMPANIES, BY REGION , 2020-2030,($MILLION)
- TABLE 21. POLYMERASE CHAIN REACTION TECHNOLOGIES MARKET BIOTECH & PHARMA COMPANIES BY COUNTRY, 2020-2030,($MILLION)
- TABLE 22. POLYMERASE CHAIN REACTION TECHNOLOGIES MARKET REVENUE, FOR ACADEMIC & RESEARCH INSTITUTIONS, BY REGION , 2020-2030,($MILLION)
- TABLE 23. POLYMERASE CHAIN REACTION TECHNOLOGIES MARKET ACADEMIC & RESEARCH INSTITUTIONS BY COUNTRY, 2020-2030,($MILLION)
- TABLE 24. POLYMERASE CHAIN REACTION TECHNOLOGIES MARKET, BY REGION, 2020-2030,($MILLION)
- TABLE 25. EUROPE POLYMERASE CHAIN REACTION TECHNOLOGIES MARKET, BY TECHNOLOGY, 2020-2030,($MILLION)
- TABLE 26. EUROPE POLYMERASE CHAIN REACTION TECHNOLOGIES MARKET, BY PRODUCT, 2020-2030,($MILLION)
- TABLE 27. EUROPE POLYMERASE CHAIN REACTION TECHNOLOGIES MARKET, BY END USERS, 2020-2030,($MILLION)
- TABLE 28. EUROPE POLYMERASE CHAIN REACTION TECHNOLOGIES MARKET, BY COUNTRY, 2020-2030,($MILLION)
- TABLE 29. GERMANY POLYMERASE CHAIN REACTION TECHNOLOGIES MARKET BY TECHNOLOGY 2020-2030,($MILLION)
- TABLE 30. GERMANY POLYMERASE CHAIN REACTION TECHNOLOGIES MARKET BY PRODUCT 2020-2030,($MILLION)
- TABLE 31. GERMANY POLYMERASE CHAIN REACTION TECHNOLOGIES MARKET BY END USERS 2020-2030,($MILLION)
- TABLE 32. UNITED KINGDOM POLYMERASE CHAIN REACTION TECHNOLOGIES MARKET BY TECHNOLOGY 2020-2030,($MILLION)
- TABLE 33. UNITED KINGDOM POLYMERASE CHAIN REACTION TECHNOLOGIES MARKET BY PRODUCT 2020-2030,($MILLION)
- TABLE 34. UNITED KINGDOM POLYMERASE CHAIN REACTION TECHNOLOGIES MARKET BY END USERS 2020-2030,($MILLION)
- TABLE 35. FRANCE POLYMERASE CHAIN REACTION TECHNOLOGIES MARKET BY TECHNOLOGY 2020-2030,($MILLION)
- TABLE 36. FRANCE POLYMERASE CHAIN REACTION TECHNOLOGIES MARKET BY PRODUCT 2020-2030,($MILLION)
- TABLE 37. FRANCE POLYMERASE CHAIN REACTION TECHNOLOGIES MARKET BY END USERS 2020-2030,($MILLION)
- TABLE 38. ITALY POLYMERASE CHAIN REACTION TECHNOLOGIES MARKET BY TECHNOLOGY 2020-2030,($MILLION)
- TABLE 39. ITALY POLYMERASE CHAIN REACTION TECHNOLOGIES MARKET BY PRODUCT 2020-2030,($MILLION)
- TABLE 40. ITALY POLYMERASE CHAIN REACTION TECHNOLOGIES MARKET BY END USERS 2020-2030,($MILLION)
- TABLE 41. REST OF EUROPE POLYMERASE CHAIN REACTION TECHNOLOGIES MARKET BY TECHNOLOGY 2020-2030,($MILLION)
- TABLE 42. REST OF EUROPE POLYMERASE CHAIN REACTION TECHNOLOGIES MARKET BY PRODUCT 2020-2030,($MILLION)
- TABLE 43. REST OF EUROPE POLYMERASE CHAIN REACTION TECHNOLOGIES MARKET BY END USERS 2020-2030,($MILLION)
- TABLE 44. ASIA-PACIFIC POLYMERASE CHAIN REACTION TECHNOLOGIES MARKET, BY TECHNOLOGY, 2020-2030,($MILLION)
- TABLE 45. ASIA-PACIFIC POLYMERASE CHAIN REACTION TECHNOLOGIES MARKET, BY PRODUCT, 2020-2030,($MILLION)
- TABLE 46. ASIA-PACIFIC POLYMERASE CHAIN REACTION TECHNOLOGIES MARKET, BY END USERS, 2020-2030,($MILLION)
- TABLE 47. ASIA-PACIFIC POLYMERASE CHAIN REACTION TECHNOLOGIES MARKET, BY COUNTRY, 2020-2030,($MILLION)
- TABLE 48. CHINA POLYMERASE CHAIN REACTION TECHNOLOGIES MARKET BY TECHNOLOGY 2020-2030,($MILLION)
- TABLE 49. CHINA POLYMERASE CHAIN REACTION TECHNOLOGIES MARKET BY PRODUCT 2020-2030,($MILLION)
- TABLE 50. CHINA POLYMERASE CHAIN REACTION TECHNOLOGIES MARKET BY END USERS 2020-2030,($MILLION)
- TABLE 51. JAPAN POLYMERASE CHAIN REACTION TECHNOLOGIES MARKET BY TECHNOLOGY 2020-2030,($MILLION)
- TABLE 52. JAPAN POLYMERASE CHAIN REACTION TECHNOLOGIES MARKET BY PRODUCT 2020-2030,($MILLION)
- TABLE 53. JAPAN POLYMERASE CHAIN REACTION TECHNOLOGIES MARKET BY END USERS 2020-2030,($MILLION)
- TABLE 54. SOUTH KOREA POLYMERASE CHAIN REACTION TECHNOLOGIES MARKET BY TECHNOLOGY 2020-2030,($MILLION)
- TABLE 55. SOUTH KOREA POLYMERASE CHAIN REACTION TECHNOLOGIES MARKET BY PRODUCT 2020-2030,($MILLION)
- TABLE 56. SOUTH KOREA POLYMERASE CHAIN REACTION TECHNOLOGIES MARKET BY END USERS 2020-2030,($MILLION)
- TABLE 57. INDIA POLYMERASE CHAIN REACTION TECHNOLOGIES MARKET BY TECHNOLOGY 2020-2030,($MILLION)
- TABLE 58. INDIA POLYMERASE CHAIN REACTION TECHNOLOGIES MARKET BY PRODUCT 2020-2030,($MILLION)
- TABLE 59. INDIA POLYMERASE CHAIN REACTION TECHNOLOGIES MARKET BY END USERS 2020-2030,($MILLION)
- TABLE 60. REST OF ASIA-PACIFIC POLYMERASE CHAIN REACTION TECHNOLOGIES MARKET BY TECHNOLOGY 2020-2030,($MILLION)
- TABLE 61. REST OF ASIA-PACIFIC POLYMERASE CHAIN REACTION TECHNOLOGIES MARKET BY PRODUCT 2020-2030,($MILLION)
- TABLE 62. REST OF ASIA-PACIFIC POLYMERASE CHAIN REACTION TECHNOLOGIES MARKET BY END USERS 2020-2030,($MILLION)
- TABLE 63. NORTH AMERICA POLYMERASE CHAIN REACTION TECHNOLOGIES MARKET, BY TECHNOLOGY, 2020-2030,($MILLION)
- TABLE 64. NORTH AMERICA POLYMERASE CHAIN REACTION TECHNOLOGIES MARKET, BY PRODUCT, 2020-2030,($MILLION)
- TABLE 65. NORTH AMERICA POLYMERASE CHAIN REACTION TECHNOLOGIES MARKET, BY END USERS, 2020-2030,($MILLION)
- TABLE 66. NORTH AMERICA POLYMERASE CHAIN REACTION TECHNOLOGIES MARKET, BY COUNTRY, 2020-2030,($MILLION)
- TABLE 67. U.S. POLYMERASE CHAIN REACTION TECHNOLOGIES MARKET BY TECHNOLOGY 2020-2030,($MILLION)
- TABLE 68. U.S. POLYMERASE CHAIN REACTION TECHNOLOGIES MARKET BY PRODUCT 2020-2030,($MILLION)
- TABLE 69. U.S. POLYMERASE CHAIN REACTION TECHNOLOGIES MARKET BY END USERS 2020-2030,($MILLION)
- TABLE 70. CANADA POLYMERASE CHAIN REACTION TECHNOLOGIES MARKET BY TECHNOLOGY 2020-2030,($MILLION)
- TABLE 71. CANADA POLYMERASE CHAIN REACTION TECHNOLOGIES MARKET BY PRODUCT 2020-2030,($MILLION)
- TABLE 72. CANADA POLYMERASE CHAIN REACTION TECHNOLOGIES MARKET BY END USERS 2020-2030,($MILLION)
- TABLE 73. MEXICO POLYMERASE CHAIN REACTION TECHNOLOGIES MARKET BY TECHNOLOGY 2020-2030,($MILLION)
- TABLE 74. MEXICO POLYMERASE CHAIN REACTION TECHNOLOGIES MARKET BY PRODUCT 2020-2030,($MILLION)
- TABLE 75. MEXICO POLYMERASE CHAIN REACTION TECHNOLOGIES MARKET BY END USERS 2020-2030,($MILLION)
- TABLE 76. LAMEA POLYMERASE CHAIN REACTION TECHNOLOGIES MARKET, BY TECHNOLOGY, 2020-2030,($MILLION)
- TABLE 77. LAMEA POLYMERASE CHAIN REACTION TECHNOLOGIES MARKET, BY PRODUCT, 2020-2030,($MILLION)
- TABLE 78. LAMEA POLYMERASE CHAIN REACTION TECHNOLOGIES MARKET, BY END USERS, 2020-2030,($MILLION)
- TABLE 79. LAMEA POLYMERASE CHAIN REACTION TECHNOLOGIES MARKET, BY COUNTRY, 2020-2030,($MILLION)
- TABLE 80. LATIN AMERICA POLYMERASE CHAIN REACTION TECHNOLOGIES MARKET BY TECHNOLOGY 2020-2030,($MILLION)
- TABLE 81. LATIN AMERICA POLYMERASE CHAIN REACTION TECHNOLOGIES MARKET BY PRODUCT 2020-2030,($MILLION)
- TABLE 82. LATIN AMERICA POLYMERASE CHAIN REACTION TECHNOLOGIES MARKET BY END USERS 2020-2030,($MILLION)
- TABLE 83. MIDDLE EAST POLYMERASE CHAIN REACTION TECHNOLOGIES MARKET BY TECHNOLOGY 2020-2030,($MILLION)
- TABLE 84. MIDDLE EAST POLYMERASE CHAIN REACTION TECHNOLOGIES MARKET BY PRODUCT 2020-2030,($MILLION)
- TABLE 85. MIDDLE EAST POLYMERASE CHAIN REACTION TECHNOLOGIES MARKET BY END USERS 2020-2030,($MILLION)
- TABLE 86. AFRICA POLYMERASE CHAIN REACTION TECHNOLOGIES MARKET BY TECHNOLOGY 2020-2030,($MILLION)
- TABLE 87. AFRICA POLYMERASE CHAIN REACTION TECHNOLOGIES MARKET BY PRODUCT 2020-2030,($MILLION)
- TABLE 88. AFRICA POLYMERASE CHAIN REACTION TECHNOLOGIES MARKET BY END USERS 2020-2030,($MILLION)
- TABLE 89.AGILENT TECHNOLOGIES: COMPANY SNAPSHOT
- TABLE 90.AGILENT TECHNOLOGIES: OPERATING SEGMENTS
- TABLE 91.AGILENT TECHNOLOGIES: PRODUCT PORTFOLIO
- TABLE 92.AGILENT TECHNOLOGIES: NET SALES,
- TABLE 93.AGILENT TECHNOLOGIES: KEY STRATERGIES
- TABLE 94. INC: COMPANY SNAPSHOT
- TABLE 95. INC: OPERATING SEGMENTS
- TABLE 96. INC: PRODUCT PORTFOLIO
- TABLE 97. INC: NET SALES,
- TABLE 98. INC: KEY STRATERGIES
- TABLE 99.BIOMERIEUX S.A: COMPANY SNAPSHOT
- TABLE 100.BIOMERIEUX S.A: OPERATING SEGMENTS
- TABLE 101.BIOMERIEUX S.A: PRODUCT PORTFOLIO
- TABLE 102.BIOMERIEUX S.A: NET SALES,
- TABLE 103.BIOMERIEUX S.A: KEY STRATERGIES
- TABLE 104.BIO-RAD LABORATORIES: COMPANY SNAPSHOT
- TABLE 105.BIO-RAD LABORATORIES: OPERATING SEGMENTS
- TABLE 106.BIO-RAD LABORATORIES: PRODUCT PORTFOLIO
- TABLE 107.BIO-RAD LABORATORIES: NET SALES,
- TABLE 108.BIO-RAD LABORATORIES: KEY STRATERGIES
- TABLE 109. INC: COMPANY SNAPSHOT
- TABLE 110. INC: OPERATING SEGMENTS
- TABLE 111. INC: PRODUCT PORTFOLIO
- TABLE 112. INC: NET SALES,
- TABLE 113. INC: KEY STRATERGIES
- TABLE 114.F. HOFFMANN-LA ROCHE AG (ROCHE): COMPANY SNAPSHOT
- TABLE 115.F. HOFFMANN-LA ROCHE AG (ROCHE): OPERATING SEGMENTS
- TABLE 116.F. HOFFMANN-LA ROCHE AG (ROCHE): PRODUCT PORTFOLIO
- TABLE 117.F. HOFFMANN-LA ROCHE AG (ROCHE): NET SALES,
- TABLE 118.F. HOFFMANN-LA ROCHE AG (ROCHE): KEY STRATERGIES
- TABLE 119.FLUIDIGM CORPORATION: COMPANY SNAPSHOT
- TABLE 120.FLUIDIGM CORPORATION: OPERATING SEGMENTS
- TABLE 121.FLUIDIGM CORPORATION: PRODUCT PORTFOLIO
- TABLE 122.FLUIDIGM CORPORATION: NET SALES,
- TABLE 123.FLUIDIGM CORPORATION: KEY STRATERGIES
- TABLE 124.LGC LIMITED: COMPANY SNAPSHOT
- TABLE 125.LGC LIMITED: OPERATING SEGMENTS
- TABLE 126.LGC LIMITED: PRODUCT PORTFOLIO
- TABLE 127.LGC LIMITED: NET SALES,
- TABLE 128.LGC LIMITED: KEY STRATERGIES
- TABLE 129.QIAGEN N.V: COMPANY SNAPSHOT
- TABLE 130.QIAGEN N.V: OPERATING SEGMENTS
- TABLE 131.QIAGEN N.V: PRODUCT PORTFOLIO
- TABLE 132.QIAGEN N.V: NET SALES,
- TABLE 133.QIAGEN N.V: KEY STRATERGIES
- TABLE 134.SYGNIS AG: COMPANY SNAPSHOT
- TABLE 135.SYGNIS AG: OPERATING SEGMENTS
- TABLE 136.SYGNIS AG: PRODUCT PORTFOLIO
- TABLE 137.SYGNIS AG: NET SALES,
- TABLE 138.SYGNIS AG: KEY STRATERGIES
- TABLE 139.TAKARA BIO INC: COMPANY SNAPSHOT
- TABLE 140.TAKARA BIO INC: OPERATING SEGMENTS
- TABLE 141.TAKARA BIO INC: PRODUCT PORTFOLIO
- TABLE 142.TAKARA BIO INC: NET SALES,
- TABLE 143.TAKARA BIO INC: KEY STRATERGIES
- TABLE 144.THERMO FISHER SCIENTIFIC INC: COMPANY SNAPSHOT
- TABLE 145.THERMO FISHER SCIENTIFIC INC: OPERATING SEGMENTS
- TABLE 146.THERMO FISHER SCIENTIFIC INC: PRODUCT PORTFOLIO
- TABLE 147.THERMO FISHER SCIENTIFIC INC: NET SALES,
- TABLE 148.THERMO FISHER SCIENTIFIC INC: KEY STRATERGIES
- LIST OF FIGURES
- FIGURE 1.POLYMERASE CHAIN REACTION TECHNOLOGIES MARKET SEGMENTATION
- FIGURE 2.POLYMERASE CHAIN REACTION TECHNOLOGIES MARKET,2020-2030
- FIGURE 3.POLYMERASE CHAIN REACTION TECHNOLOGIES MARKET,2020-2030
- FIGURE 4. TOP INVESTMENT POCKETS, BY REGION
- FIGURE 5.PORTER FIVE-1
- FIGURE 6.PORTER FIVE-2
- FIGURE 7.PORTER FIVE-3
- FIGURE 8.PORTER FIVE-4
- FIGURE 9.PORTER FIVE-5
- FIGURE 10.TOP PLAYER POSITIONING
- FIGURE 11.POLYMERASE CHAIN REACTION TECHNOLOGIES MARKET:DRIVERS, RESTRAINTS AND OPPORTUNITIES
- FIGURE 11.POLYMERASE CHAIN REACTION TECHNOLOGIES MARKET,BY TECHNOLOGY,2020(%)
- FIGURE 12.COMPARATIVE SHARE ANALYSIS OF REAL-TIME PCR POLYMERASE CHAIN REACTION TECHNOLOGIES MARKET,2020-2030(%)
- FIGURE 13.COMPARATIVE SHARE ANALYSIS OF TRADITIONAL PCR POLYMERASE CHAIN REACTION TECHNOLOGIES MARKET,2020-2030(%)
- FIGURE 14.COMPARATIVE SHARE ANALYSIS OF DIGITAL PCR POLYMERASE CHAIN REACTION TECHNOLOGIES MARKET,2020-2030(%)
- FIGURE 15.POLYMERASE CHAIN REACTION TECHNOLOGIES MARKET,BY PRODUCT,2020(%)
- FIGURE 16.COMPARATIVE SHARE ANALYSIS OF REAGENTS & CONSUMABLES POLYMERASE CHAIN REACTION TECHNOLOGIES MARKET,2020-2030(%)
- FIGURE 17.COMPARATIVE SHARE ANALYSIS OF INSTRUMENTS POLYMERASE CHAIN REACTION TECHNOLOGIES MARKET,2020-2030(%)
- FIGURE 18.COMPARATIVE SHARE ANALYSIS OF SOFTWARE POLYMERASE CHAIN REACTION TECHNOLOGIES MARKET,2020-2030(%)
- FIGURE 19.COMPARATIVE SHARE ANALYSIS OF SERVICES POLYMERASE CHAIN REACTION TECHNOLOGIES MARKET,2020-2030(%)
- FIGURE 20.POLYMERASE CHAIN REACTION TECHNOLOGIES MARKET,BY END USERS,2020(%)
- FIGURE 21.COMPARATIVE SHARE ANALYSIS OF DIAGNOSTIC CENTERS & HOSPITALS POLYMERASE CHAIN REACTION TECHNOLOGIES MARKET,2020-2030(%)
- FIGURE 22.COMPARATIVE SHARE ANALYSIS OF BIOTECH & PHARMA COMPANIES POLYMERASE CHAIN REACTION TECHNOLOGIES MARKET,2020-2030(%)
- FIGURE 23.COMPARATIVE SHARE ANALYSIS OF ACADEMIC & RESEARCH INSTITUTIONS POLYMERASE CHAIN REACTION TECHNOLOGIES MARKET,2020-2030(%)
- FIGURE 24.POLYMERASE CHAIN REACTION TECHNOLOGIES MARKET BY REGION,2020
- FIGURE 25.GERMANY POLYMERASE CHAIN REACTION TECHNOLOGIES MARKET,2020-2030($MILLION)
- FIGURE 26.UNITED KINGDOM POLYMERASE CHAIN REACTION TECHNOLOGIES MARKET,2020-2030($MILLION)
- FIGURE 27.FRANCE POLYMERASE CHAIN REACTION TECHNOLOGIES MARKET,2020-2030($MILLION)
- FIGURE 28.ITALY POLYMERASE CHAIN REACTION TECHNOLOGIES MARKET,2020-2030($MILLION)
- FIGURE 29.REST OF EUROPE POLYMERASE CHAIN REACTION TECHNOLOGIES MARKET,2020-2030($MILLION)
- FIGURE 30.CHINA POLYMERASE CHAIN REACTION TECHNOLOGIES MARKET,2020-2030($MILLION)
- FIGURE 31.JAPAN POLYMERASE CHAIN REACTION TECHNOLOGIES MARKET,2020-2030($MILLION)
- FIGURE 32.SOUTH KOREA POLYMERASE CHAIN REACTION TECHNOLOGIES MARKET,2020-2030($MILLION)
- FIGURE 33.INDIA POLYMERASE CHAIN REACTION TECHNOLOGIES MARKET,2020-2030($MILLION)
- FIGURE 34.REST OF ASIA-PACIFIC POLYMERASE CHAIN REACTION TECHNOLOGIES MARKET,2020-2030($MILLION)
- FIGURE 35.U.S. POLYMERASE CHAIN REACTION TECHNOLOGIES MARKET,2020-2030($MILLION)
- FIGURE 36.CANADA POLYMERASE CHAIN REACTION TECHNOLOGIES MARKET,2020-2030($MILLION)
- FIGURE 37.MEXICO POLYMERASE CHAIN REACTION TECHNOLOGIES MARKET,2020-2030($MILLION)
- FIGURE 38.LATIN AMERICA POLYMERASE CHAIN REACTION TECHNOLOGIES MARKET,2020-2030($MILLION)
- FIGURE 39.MIDDLE EAST POLYMERASE CHAIN REACTION TECHNOLOGIES MARKET,2020-2030($MILLION)
- FIGURE 40.AFRICA POLYMERASE CHAIN REACTION TECHNOLOGIES MARKET,2020-2030($MILLION)
- FIGURE 41. TOP WINNING STRATEGIES, BY YEAR
- FIGURE 42. TOP WINNING STRATEGIES, BY DEVELOPMENT
- FIGURE 43. TOP WINNING STRATEGIES, BY COMPANY
- FIGURE 44.PRODUCT MAPPING OF TOP 10 PLAYERS
- FIGURE 45.COMPETITIVE DASHBOARD
- FIGURE 46.COMPETITIVE HEATMAP OF TOP 10 KEY PLAYERS
- FIGURE 47.AGILENT TECHNOLOGIES.: NET SALES ,($MILLION)
- FIGURE 48. INC.: NET SALES ,($MILLION)
- FIGURE 49.BIOMERIEUX S.A.: NET SALES ,($MILLION)
- FIGURE 50.BIO-RAD LABORATORIES.: NET SALES ,($MILLION)
- FIGURE 51. INC.: NET SALES ,($MILLION)
- FIGURE 52.F. HOFFMANN-LA ROCHE AG (ROCHE).: NET SALES ,($MILLION)
- FIGURE 53.FLUIDIGM CORPORATION.: NET SALES ,($MILLION)
- FIGURE 54.LGC LIMITED.: NET SALES ,($MILLION)
- FIGURE 55.QIAGEN N.V.: NET SALES ,($MILLION)
- FIGURE 56.SYGNIS AG.: NET SALES ,($MILLION)
- FIGURE 57.TAKARA BIO INC.: NET SALES ,($MILLION)
- FIGURE 58.THERMO FISHER SCIENTIFIC INC.: NET SALES ,($MILLION)
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
